Water → HCID 86730138, compound
Reaction equation
[Cl:1][C:2]1[N:7]=[C:6](Cl)[CH:5]=[CH:4][N:3]=1.[C:9]1([C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=2)[CH:14]=[CH:13][C:12]([C@H:15]2[CH2:19][O:18][C:17](=[O:20])[NH:16]2)=[CH:11][CH:10]=1.[H-].[Na+].O>CN(C=O)C.CCOC(C)=O.[Cl-].[Na+].O>[C:9]1([C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=2)[CH:14]=[CH:13][C:12]([C@H:15]2[CH2:19][O:18][C:17](=[O:20])[N:16]2[C:6]2[CH:5]=[CH:4][N:3]=[C:2]([Cl:1])[N:7]=2)=[CH:11][CH:10]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
To a solution of 2,4-dichloropyrimidine (46.5 mg, 0.312 mmol) and (S)-4-(biphenyl-4-yl)oxazolidin-2-one (74.7 mg, 0.312 mmol) in DMF (700 μL) was added NaH (60% wt., 10.49 mg, 0.437 mmol) in two portions within ˜5 min [Caution: exotherm; gas development] at room temperature (water bath). The reaction mixture was stirred for 1.5 hour. The mixture was diluted with EtOAc (25 mL), stirred for 5 min and then diluted slowly with diluted brine (10 mL; 1:1 brine/water). The mixture was poured into diluted brine (40 mL) and EtOAc (25 mL). The separated organic phase was washed with diluted brine (3×40 ml), dried over Na2SO4, filtered off and concentrated under reduced pressure. The residue was purified by column chromatography [SiO2, 40 g, EtOAc/heptane] to provide (S)-4-(biphenyl-4-yl)-3-(2-chloropyrimidin-4-yl)oxazolidin-2-one (49.5 mg). LCMS m/z 352.2 (M+H)+, Rt 1.06 min.
Workup
- stirringstirred for 5 min
- washThe separated organic phase was washed with diluted brine (3×40 ml)
- dry with materialdried over Na2SO4
- filtrationfiltered off
- concentrationconcentrated under reduced pressure
- customThe residue was purified by column chromatography [SiO2, 40 g, EtOAc/heptane]
Sources & evidence
- ORD record
- ord-ed3f86bd375849cc947d2c4ff163b12b
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08957068B2
Reaction notes
Loading…